These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24691172)

  • 21. Would you bet on PET? Evaluation of the significance of positive PET scan results post-microwave ablation for non-small cell lung cancer.
    Zaheer SN; Whitley JM; Thomas PA; Steinke K
    J Med Imaging Radiat Oncol; 2015 Dec; 59(6):702-12. PubMed ID: 26041618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of bone scintigraphy and (18)F-FDG PET/CT in bone metastases of lung cancer patients].
    Portilla-Quattrociocchi H; Banzo I; Martínez-Rodríguez I; Quirce R; Jiménez-Bonilla J; de Arcocha Torres M; Medina-Quiroz P; del Castillo R; Rubio-Vassallo A; Carril JM
    Rev Esp Med Nucl; 2011; 30(1):2-7. PubMed ID: 21208693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual-time point scanning of integrated FDG PET/CT for the evaluation of mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT.
    Kasai T; Motoori K; Horikoshi T; Uchiyama K; Yasufuku K; Takiguchi Y; Takahashi F; Kuniyasu Y; Ito H
    Eur J Radiol; 2010 Aug; 75(2):143-6. PubMed ID: 19446975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. False-positive 18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET/CT) scans mimicking malignancies.
    Yasar Z; Acat M; Onaran H; H Dincer E; Cetinkaya E; A Korkmaz N; Ozgül A
    Med Glas (Zenica); 2015 Feb; 12(1):40-6. PubMed ID: 25669335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.
    Bollineni VR; Widder J; Pruim J; Langendijk JA; Wiegman EM
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e551-5. PubMed ID: 22417800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occult lung infarction may induce false interpretation of 18F-FDG PET in primary staging of pulmonary malignancies.
    Kamel EM; McKee TA; Calcagni ML; Schmidt S; Markl S; Castaldo S; Delaloye AB
    Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):641-6. PubMed ID: 15726357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing the accuracy of 18F-FDG PET/CT interpretation of "mildly positive" mediastinal nodes in the staging of non-small cell lung cancer.
    Moloney F; Ryan D; McCarthy L; McCarthy J; Burke L; Henry MT; Kennedy MP; Hinchion J; McSweeney S; Maher MM; O'Regan K
    Eur J Radiol; 2014 May; 83(5):843-7. PubMed ID: 24581594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
    Nakamura H; Saji H; Marushima H; Kimura H; Tagaya R; Kurimoto N; Hoshikawa M; Takagi M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1388-93. PubMed ID: 25900205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.
    Been LB; Hoekstra HJ; Suurmeijer AJ; Jager PL; van der Laan BF; Elsinga PH
    Oral Oncol; 2009 Dec; 45(12):e211-5. PubMed ID: 19692292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pattern and predictors of false positive lymph node involvement on positron emission tomography in patients with non-small cell lung cancer.
    Tamura M; Oda M; Matsumoto I; Waseda R; Watanabe G
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):105-10. PubMed ID: 21789758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
    Lee JW; Na JO; Kang DY; Lee SY; Lee SM
    Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma.
    Nomori H; Shibata H; Uno K; Iyama K; Honda Y; Nakashima R; Sakaguchi K; Goya T; Takanami I; Koizumi K; Suzuki T; Kaji M; Horio H
    J Thorac Oncol; 2008 Dec; 3(12):1427-32. PubMed ID: 19057268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size.
    Tsunezuka Y; Shimizu Y; Tanaka N; Takayanagi T; Kawano M
    World J Surg; 2007 Feb; 31(2):314-7. PubMed ID: 17219276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of efficacy and clinical impact of FDG-PET on patients with potentially resectable non-small cell lung cancer].
    Borrego Dorado I; López García C; Vázquez Albertino R; Ginel Cañamaque A; Barrot Cortés E
    Rev Esp Med Nucl; 2007; 26(6):335-44. PubMed ID: 18021687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of sublobar resection for c-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET.
    Yoshioka M; Ichiguchi O
    Ann Thorac Cardiovasc Surg; 2009 Apr; 15(2):82-8. PubMed ID: 19471220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography.
    Harders SW; Madsen HH; Hjorthaug K; Arveschoug AK; Rasmussen TR; Meldgaard P; Hoejbjerg JA; Pilegaard HK; Hager H; Rehling M; Rasmussen F
    Cancer Imaging; 2014 Jun; 14(1):23. PubMed ID: 25608616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PET/CT in non-small cell lung cancer staging-promises and problems.
    Devaraj A; Cook GJ; Hansell DM
    Clin Radiol; 2007 Feb; 62(2):97-108. PubMed ID: 17207691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.